Literature DB >> 24573210

Spontaneous thrombosis of the abdominal aorta in two neonates.

F Piersigilli1, C Auriti1, F Landolfo1, F Campi1, P Schingo2, A Dotta1.   

Abstract

Although relatively rare, thromboembolic events are a major complication of invasive procedures, mainly vascular catheterization, required for the survival of neonates admitted to the neonatal intensive care unit. Sometimes symptoms may be ambiguous and the diagnosis may not be immediate. The clinical relevance of polymorphism of methilene tetrahydrofolate reductase (MTHFR) gene heterozigosity and of omocystein level in the genesis of these thromboembolic events are poorly understood. We report two cases of thrombosis of the abdominal aorta, mimicking aortic coarctation, in two neonates, successfully treated at diagnosis with 170 UI/Kg of low molecular weight heparin (LMWH) twice daily, without side effects. Screening for prothrombotic defects revealed the heterozygosity for MTHFR C677T in both neonates and low omocystein level in one of them. We suggest that in newborns vascular thrombosis should be considered in the differential diagnosis of acute disorders of blood circulation at birth and familial thrombophilia should be investigated. LMWH therapy with a dose of 170 UI/Kg twice daily usually allows vascular recanalization, without side effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573210     DOI: 10.1038/jp.2013.154

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  10 in total

1.  Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.

Authors:  N Münchow; A Kosch; R Schobess; R Junker; K Auberger; U Nowak-Göttl
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

2.  Spontaneous aortic thrombosis in a neonate presenting as coarctation.

Authors:  R M Hamilton; P A Penkoske; P Byrne; N F Duncan
Journal:  Ann Thorac Surg       Date:  1988-05       Impact factor: 4.330

3.  Neonatal symptomatic thromboembolism in Germany: two year survey.

Authors:  U Nowak-Göttl; R von Kries; U Göbel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

4.  Neonatal thrombosis: report of a prospective Canadian and international registry.

Authors:  B Schmidt; M Andrew
Journal:  Pediatrics       Date:  1995-11       Impact factor: 7.124

Review 5.  Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates.

Authors:  Janet I Malowany; Paul Monagle; David C Knoppert; David S C Lee; John Wu; Patricia McCusker; M Patricia Massicotte; Suzan Williams; Anthony K C Chan
Journal:  Thromb Res       Date:  2008-01-18       Impact factor: 3.944

Review 6.  Neonatal aortic arch thrombosis: analysis of thrombophilic risk factors and prognosis.

Authors:  Ivonne Wieland; Thomas Jack; Kathrin Seidemann; Martin Boehne; Florian Schmidt; Christoph M Happel; Harald Koeditz; Harald Bertram; Michael Sasse
Journal:  Cardiol Young       Date:  2013-01-21       Impact factor: 1.093

7.  Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Paul Monagle; Elizabeth Chalmers; Anthony Chan; Gabrielle deVeber; Fenella Kirkham; Patricia Massicotte; Alan D Michelson
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Enoxaparin use in the neonatal intensive care unit: experience over 8 years.

Authors:  Janet I Malowany; David C Knoppert; Anthony K C Chan; Dion Pepelassis; David S C Lee
Journal:  Pharmacotherapy       Date:  2007-09       Impact factor: 4.705

9.  Spontaneous aortic thrombosis in a neonate with multiple thrombi in the main branches of the abdominal aorta.

Authors:  Y Kawahira; H Kishimoto; M Lio; S Ikawa; Y Kume; N Inamura; T Matushita; T Maeno; T Nakada
Journal:  Cardiovasc Surg       Date:  1995-04

10.  Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants.

Authors:  Marije Hogeveen; Henk J Blom; Marjolein Van Amerongen; Bas Boogmans; Ingrid M Van Beynum; Margot Van De Bor
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.